MB-11055

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMB-11055
Drug Alias NameMB-11055
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsFibrosisObesityMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKt&G Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKt&G Life Sciences
Active IndicationsN/A
Inactive IndicationsFibrosisObesityMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A